University Department of Paediatrics and Neonatology, Children’s Hospital of Saarland, Homburg, Germany.
Swiss Med Wkly. 2013 May 27;143:w13794. doi: 10.4414/smw.2013.13794. eCollection 2013.
A high prevalence of complementary and alternative medicine (CAM) use has been documented in children with chronic illnesses. Conversely, evidence-based medicine is considered an important contributor in providing the best quality of care.
We performed a systematic overview/synthesis of all Cochrane reviews published between 1995 and 2012 in paediatrics that assessed the efficacy, and clinical implications and limitations of CAM use in children. Main outcome variables were: percentage of reviews that concluded that a certain intervention provides a benefit, percentage of reviews that concluded that a certain intervention should not be performed, and percentage of studies that concluded that the current level of evidence is inconclusive.
A total of 135 reviews were included - most from the United Kingdom (29/135), Australia (24/135) and China (24/135). Only 5/135 (3.7%) reviews gave a recommendation in favour of a certain intervention; 26/135 (19.4%) issued a conditional positive recommendation, and 9/135 (6.6%) reviews concluded that certain interventions should not be performed. Ninety-five reviews (70.3%) were inconclusive. The proportion of inconclusive reviews increased during three, a priori-defined, time intervals (1995-2000: 15/27 [55.6%]; 2001-2006: 33/44 [75%]; and 2007-2012: 47/64 [73.4%]). The three most common criticisms of the quality of the studies included were: more research needed (82/135), low methodological quality (57/135) and small number of study participants (48/135).
Given the disproportionate number of inconclusive reviews, there is an ongoing need for high quality research to assess the potential role of CAM in children. Unless the study of CAM is performed to the same science-based standards as conventional therapies, CAM therapies risk being perpetually marginalised by mainstream medicine.
有研究表明,慢性病儿童普遍采用补充和替代医学(CAM)。而循证医学被认为是提供最佳医疗质量的重要手段。
我们对 1995 年至 2012 年间发表的所有评估儿童 CAM 应用的疗效、临床意义和局限性的 Cochrane 综述进行了系统评价/综合。主要观察指标为:得出某种干预有益结论的综述比例、得出某种干预不应进行的综述比例,以及得出当前证据水平不确定结论的研究比例。
共纳入 135 项综述,其中大部分来自英国(29/135)、澳大利亚(24/135)和中国(24/135)。仅有 5/135(3.7%)项综述推荐某种干预措施;26/135(19.4%)项综述给出有条件的积极推荐;9/135(6.6%)项综述认为某些干预不应进行。95 项综述(70.3%)的结论不确定。在三个预先设定的时间段内,不确定综述的比例逐渐增加(1995-2000 年:27 项综述中有 15 项[55.6%];2001-2006 年:44 项综述中有 33 项[75%];2007-2012 年:64 项综述中有 47 项[73.4%])。对研究质量最常见的三项批评包括:需要更多研究(82/135)、方法学质量低(57/135)和研究参与者数量少(48/135)。
鉴于不确定综述的比例过高,需要进行高质量的研究来评估 CAM 在儿童中的潜在作用。除非 CAM 的研究符合与常规疗法相同的基于科学的标准,否则 CAM 疗法可能会一直被主流医学边缘化。